|
|
Αιματολογία |
|
Μελέτη PASS |
Amgen Hellas |
A cross-sectional study of patients with immune thrombocytopenic purpura and caregivers to estimate the proportion who administer romiplostim correctly after receipt of home administration training materials
|
20120269 |
εμφάνιση |
|
|
Γενική Ιατρική |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Amgen Hellas |
A Cross-sEctional Study to collect data on 10 year fracture risk in a population of post-menopausal women with Osteopenia, not receiving osteoporosis treatment, in routine clinical care in Greece |
20120285 -ACROSS |
εμφάνιση |
|
|
Παιδιατρική |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
MSD |
A Hellenic Non-Interventional Prospective Observational Study to Determine the Prevalence of PNEUmococcal Serotypes, Management Strategies, Clinical Outcomes and Resource Utilization in Pediatric Patients Diagnosed with Pneumococcal DISeases in Real-World Clinical Settings
|
PNEUSIS |
εμφάνιση |
|
|
Ακτινοθεραπευτική - Ογκολογία |
NA |
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Astrazeneca |
A Hellenic Retrospective Chart Review Study to Characterize the Patient Profile and to Capture the Real-World Management Strategies and their Outcomes in the Second-Line Setting and Beyond of Metastatic HER2-Positive Breast Cancer |
TOGETHER |
εμφάνιση |
|
|
Ακτινοθεραπευτική - Ογκολογία |
NA |
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Astrazeneca |
A HELLENIC RETROSPECTIVE CHART REVIEW STUDY TO PROVIDE REAL-WORLD EVIDENCE ON THE MANAGEMENT STRATEGIES, THEIR SEQUENCING PATTERNS AND OUTCOMES IN NEWLY-DIAGNOSED ADVANCED EPITHELIAL OVARIAN CANCER |
EPOCA |
εμφάνιση |
|
|
Παθολογία |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Astrazeneca |
A HelleNic, real-world, multicenter, cross-sectional and retrospective chart review studY to assess disease activity and organ damage as well as to characterize the patient profile, management strategies, and the patient-reported burden associated with systeMic lupus ERythematosus in routIne cAre settings |
NYMERIA |
εμφάνιση |
|
|
Γαστρεντερολογία |
HUMIRA |
Μη παρεμβατική μελέτη με φάρμακο |
AbbVie Φαρμακευτική Α.Ε. |
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of Humira® (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease (CD) – CAPE |
CAPE |
εμφάνιση |
|
|
Νεφρολογία |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Astrazeneca |
A multicenter proSPective observatIonal study of patients newly diagnosed with decReased eGFR, treated by primary care physIcians or hospital-based nephrologists to assess Treatment patterns, disease management and quality of life in Greece |
SPIRIT |
εμφάνιση |
|
|
Γαστρεντερολογία |
Simponi |
Μη παρεμβατική μελέτη με φάρμακο |
MSD |
A multicenter, non-interventional, observational study to assess the effect of Simponi® (GOlimumab) on quality of LIFE, healthcare resource utilization and work productivity among patients with ulcerative colitis in real world clinical setting in Greece |
GO-LIFE |
εμφάνιση |
|
|
Πνευμονολογία - Φυματολογία |
Esbriet |
Μη παρεμβατική μελέτη με φάρμακο |
Roche Hellas |
A MULTICENTER, POST-MARKETING, NON-INTERVENTIONAL, OBSERVATIONAL STUDY TO EVALUATE QUALITY OF LIFE IN PATIENTS IN GREECE WITH IDIOPATHIC PULMONARY FIBROSIS UNDER TREATMENT WITH PIRFENIDONE |
PNEUMON |
εμφάνιση |
